JPRN-UMIN000011882已完成2 期
Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapy - Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapy
Teikyo University School of Medicine0 个研究点目标入组 21 人开始时间: 2013年9月30日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.History of serious drug hypersensitivity 2.Any other serious illness or medical conditions including interstitial pneumonia or pulmonary fibrosis, renal failure, liver failure,cerebrovascular disordar or Uncontrolled diabates 3.Active infection or fever suspicious of infection. 4.Surgical procedure within 4 weeks before registration 5.Uncontrolled unstable angina, congestive heart failure, myocardial infarction or ventricular arrhythmia 6.History of mental disorder, central nerve disorder. 7.Pregnant women, nursing mothers 8.Patients who were considered by the primary care physician to be inappropriate for this trial
研究者
相似试验
已完成
不适用
Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapyadvanced advanced for gastric cancer patients with prior chemotherapyJPRN-UMIN000013105Toho University Graduate School of Medicine25
招募中
不适用
Phase II trial of weekly Nab-Paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer.Advanced Gastric CancerJPRN-UMIN000015968Tottori University35
已完成
1 期
Phase I/II trial of weekly nab-paclitaxel as second- or third-line treatment in patients with advanced non-small-cell lung cancer(OLCSG1303)on-small Cell Lung CancerJPRN-UMIN000012404Okayama Lung Cancer Study Group (OLCSG)55
已完成
2 期
A phase 2 trial of weekly nab-paclitaxel for advanced non-small cell lung cancer without EGFR mutation nor ALK fusion gene in salvage settingJPRN-UMIN000016173Kurashiki Central Hospital38
进行中（未招募）
1 期
Phase II trial of nab-paclitaxel for the treatment of desmoid tumors and multiply relapsed/refractory desmoplastic small round cell tumors and Ewing sarcomaEUCTR2016-002464-14-ESGrupo Español de Investigación en Sarcomas (GEIS)61